Additionally, western blotting results demonstrated that Z-GS suppressed EMT in breast cancer cells by upregulating the epithelial markers E-Cadherin and downregulating the mesenchymal markers N-cadherin and vimentin (Fig. 3F, G). Here, CDH2 is linked to breast cancer.